Streetbeat News

Price Targets

UAL

Citigroup analyst Stephen Trent has maintained a 'Buy' rating on United Airlines Holdings (NASDAQ:UAL) but lowered the price target from $76 to $71.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 11:18 am

GPCR

JMP Securities analyst Jonathan Wolleben has initiated coverage on Structure Therapeutics (NASDAQ:GPCR) with a Market Outperform rating and a price target of $90.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 11:14 am

ALLY

Citigroup analyst Arren Cyganovich has maintained a 'Buy' rating on Ally Financial (NYSE:ALLY) but lowered the price target from $37 to $35.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 11:11 am

PRLD

HC Wainwright & Co. analyst Robert Burns maintains a 'Buy' rating on Prelude Therapeutics (NASDAQ:PRLD) but has lowered the price target from $17 to $6.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 11:06 am

PXD

TD Cowen analyst David Deckelbaum has downgraded Pioneer Natural Resources (NYSE:PXD) from Outperform to Market Perform and lowered the price target from $280 to $256.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 11:01 am

GOOS

TD Cowen analyst Oliver Chen has downgraded Canada Goose Holdings (NYSE:GOOS) from Outperform to Market Perform and lowered the price target from $22 to $15.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 10:58 am

GPK

Wells Fargo analyst Gabe Hajde has downgraded Graphic Packaging Holding (NYSE:GPK) from Overweight to Underweight and lowered the price target from $26 to $19.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 10:54 am

HALO

HC Wainwright & Co. analyst Mitchell Kapoor maintains a 'Buy' rating on Halozyme Therapeutics (NASDAQ:HALO) and raises the price target from $60 to $61.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 10:54 am

CARA

HC Wainwright & Co. analyst Oren Livnat maintains a 'Buy' rating on Cara Therapeutics (NASDAQ:CARA) but has lowered the price target from $15 to $7.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 10:49 am

DHT

Stifel analyst Benjamin Nolan has downgraded DHT Holdings (NYSE:DHT) from Buy to Hold and set a price target of $11.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 10:47 am